November 18, 2026

Keith Grimes in conversation with the Faculty of Pharmaceutical Medicine

Our founder and CEO, Dr Keith Grimes, features in the latest FPM Voices Q&A from the Faculty of Pharmaceutical Medicine (FPM), a series that shares the careers and insights of senior and influential physicians in the field. Keith is a Fellow of the FPM and sits on its New Technologies Expert Group.

Using his hands-on experience working with providers and manufacturers, Keith talks about the current state of clinical safety in the NHS. A 2025 study he co-authored with Curistica’s Dr Youssof Oskrochi and colleagues published in the Journal of Medical Internet Research found that around 70% of digital health technologies affecting patient care in NHS England had no documented clinical safety assurance. Fewer than one in five were fully assured against DCB0129 and DCB0160. He reflects on the challenges clinicians can face using ambient scribes and why they need to stay actively involved. He also explains why we shouldn’t assume technology is safe just because it works, and why it deserves the same rigour we expect of medicines.

Highlighting the importance of nurturing the humans using the technology, he explains why clinicians who develop and deploy health technology need a proper professional home and training pathway as pharmaceutical medicine has. He also speaks openly about his own burnout and recovery and how that has shaped the way he thinks about clinical careers.

For practice teams using or considering AI tools, the interview is a useful look at why clinical safety matters and what it involves day to day.

Read the full Q&A on the FPM website